Arkolith/Insider Trading/ADCT/Form 4

Redmile Group, LLC

10% OwnerADC Therapeutics SA (ADCT) · full profile →Form 4 · filed Jun 13, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 11, 2025Buy(P)12.5M$3.43$42.8M12.5M
Jun 11, 2025Buy(P)15.7M$3.43$54.0M15.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-059489) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML